Novavax Stock

• Vaccine maker Novavax, despite concerns for its future, to maintain partnership with Ottawa

  In an effort to get COVID-19 vaccines made in Canada, the federal government announced in February 2021 a deal between with Novavax to begin producing its vaccine in Montreal. 

  Health

  Mar 2, 2023
  
• Novavax shares plunge after COVID-19 vaccine maker raises doubts over its future

  Novavax — whose COVID-19 vaccine is its only marketed product after 35 years in business — on Tuesday flagged significant uncertainty around its 2023 revenue.

  World

  Mar 1, 2023
  
• Advertisement
• U.S. IP waiver support rocks COVID-19 vaccine makers

  Pfizer, Moderna, Novavax and U.S. shares of BioNTech were down between four per cent and 10 per cent on Thursday.

  Money

  May 6, 2021